Regulatory/Validation

IBC has taken the lead to bring all the industry experts together to give you the answers you need to move ahead your discovery, design or development program. This is the first program to combine coverage of ADCs and other bioconjugates so you can expand your knowledge base and move your programs efficiently ahead from bench to bedside.

IBC's 5th Annual BioProcess International China conference provides you with practical tools, techniques and strategies to improve your upstream and downstream development efforts and offer you insights into state-of-the-art approaches for GMP manufacturing and scale-up that meet international standards.

The biopharmaceutical industry's premier event. It is the one place where you know you will meet with the key players in the field. BPI is your industry resource to expand your knowledge with unparalleled access to new, unpublished data and exclusive case studies from companies of all sizes and perspectives. Your attendance prepares your bioprocess operations for success in the highly dynamic market for biologics.

IBC's Well Characterized Biologicals conference is the leading industry conference to provide case studies, CMC strategies and regulatory perspectives on protein characterization and product comparability for biotechnology products and biosimilars throughout the product lifecycle.

IBC's Inaugural Product and Process Variants & Impurities conference explores the major classes of productand process-related impurities that can affect the safety, efficacy, and overall structure of a molecule targeted for a biologic or protein therapeutic.

IBC's Flexible Facilities conference is designed to bring together thought leaders from biologics drug developers, engineering firms, CMOs, technology providers and governmental bodies to share best practices and new ideas.

IBC's Biopharmaceutical Development & Production Week provides you with practical Methods and techniques to help you navigate the development, production and regulatory challenges of an emerging wave of new Molecules progressing through the biopharmaceutical pipeline.